Market Overview:
The global transdermal nicotine patch market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of smoking-related diseases, rising awareness about the benefits of quitting smoking, and technological advancements in transdermal nicotine patches. The global transdermal nicotine patch market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 7mg/24hrs, 14mg/24hrs, 21mg/24hrs 10mg/16hrs 15mg/16 hrs 25 mg / 16 hrs .On the basis of application ,the market is segmented into withdrawal clinics medical practice individual smokers others .On t he basis o f region ,t he m arket i s segmen ted int o North America Latin America Europe Asia Pacific Middle East & Africa .
Product Definition:
A transdermal nicotine patch is a device that delivers nicotine through the skin. It is used to help people stop smoking cigarettes. Nicotine replacement therapy (NRT) with a transdermal nicotine patch can double or even triple your chances of quitting smoking successfully.
7mg/24hrs:
7mg/24hrs is a nicotine transdermal patch with an active ingredient that delivers the same amount of nicotine as would be present in 3-4 normal cigarettes. The product was developed by British American Tobacco and launched in 2014, since then it has gained huge popularity across the globe.
The market for 7mg/24hrs patches is growing at a significant rate owing to its increasing adoption among smokers who are trying to quit or reduce their cigarette consumption.
14mg/24hrs:
14mg/24hrs is a nicotine transdermal patch with the formulation of delivering nicotine through the skin. It contains 14 mg of nicotine and has a delivery system that provides 24 hours supply of nicotine. The product was first launched in 2015 and currently available in various countries such as Australia, Canada, U.S., Germany, South Africa & Japan among others.
Application Insights:
The other application segment includes the use of transdermal nicotine patches for pain management, smoking cessation and weight loss. Withdrawal clinics were the largest application segment in 2017 and are expected to grow at a significant rate over the forecast period. The high success rate associated with these patches is one of the major factors responsible for their large share.
Medical practice is estimated to be one of the fastest-growing segments during the forecast period due to increasing awareness about health issues among individuals, organizations and government agencies across various regions including North America, Europe, Asia Pacific and Middle East & Africa. For instance; The World Health Organization (WHO) has declared tobacco as carcinogenic substance which causes cancer as well as diseases such as Chronic Obstructive Pulmonary Disease (COPD). This fact alone will increase product demand in near future.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high awareness levels regarding transdermal nicotine patch products, presence of well-established healthcare infrastructure and availability of skilled professionals. Moreover, increasing smoking prevalence coupled with rising disposable income is anticipated to fuel demand for these patches in North America over the forecast period.
Asia Pacific also holds a prominent share due to growing number of smokers and high unmet needs pertaining to tobacco dependence treatment options across emerging economies such as India and China. Furthermore, favorable government initiatives aimed at reducing smoking prevalence are expected drive regional growth over the next eight years.
Growth Factors:
- Increasing awareness about the health hazards of smoking and the benefits of quitting smoking
- Growing number of smokers who are looking for an easier way to quit smoking
- Rising demand for smokeless tobacco products and nicotine replacement therapies (NRTs)
- Technological advancements in transdermal nicotine patch manufacturing that improve product efficacy and safety
- Increasing number of clinical studies that demonstrate the benefits of transdermal nicotine patches
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Nicotine Patch Market Research Report
By Type
7mg/24hrs, 14mg/24hrs, 21mg/24hrs, 10mg/16hrs, 15mg/16hrs, 25mg/16hrs
By Application
Withdrawal Clinics, Medical Practice, Individual Smokers, Others
By Companies
GlaxoSmithKline, Novartis, Johnson & Johnson, Perrigo Company, Mylan, Dr. Reddy's Laboratories, Rusan Pharma, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Nicotine Patch Market Report Segments:
The global Transdermal Nicotine Patch market is segmented on the basis of:
Types
7mg/24hrs, 14mg/24hrs, 21mg/24hrs, 10mg/16hrs, 15mg/16hrs, 25mg/16hrs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Withdrawal Clinics, Medical Practice, Individual Smokers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Novartis
- Johnson & Johnson
- Perrigo Company
- Mylan
- Dr. Reddy's Laboratories
- Rusan Pharma
- GlaxoSmithKline
Highlights of The Transdermal Nicotine Patch Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 7mg/24hrs
- 14mg/24hrs
- 21mg/24hrs
- 10mg/16hrs
- 15mg/16hrs
- 25mg/16hrs
- By Application:
- Withdrawal Clinics
- Medical Practice
- Individual Smokers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Nicotine Patch Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transdermal nicotine patch is a type of medication that goes on the skin and releases nicotine over time. It is usually worn on the skin near the chest, stomach, or back.
Some of the key players operating in the transdermal nicotine patch market are GlaxoSmithKline, Novartis, Johnson & Johnson, Perrigo Company, Mylan, Dr. Reddy's Laboratories, Rusan Pharma, GlaxoSmithKline.
The transdermal nicotine patch market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transdermal Nicotine Patch Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Transdermal Nicotine Patch Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Transdermal Nicotine Patch Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Transdermal Nicotine Patch Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Transdermal Nicotine Patch Market Size & Forecast, 2020-2028
4.5.1 Transdermal Nicotine Patch Market Size and Y-o-Y Growth
4.5.2 Transdermal Nicotine Patch Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 7mg/24hrs
5.2.2 14mg/24hrs
5.2.3 21mg/24hrs
5.2.4 10mg/16hrs
5.2.5 15mg/16hrs
5.2.6 25mg/16hrs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Withdrawal Clinics
6.2.2 Medical Practice
6.2.3 Individual Smokers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transdermal Nicotine Patch Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transdermal Nicotine Patch Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 7mg/24hrs
9.6.2 14mg/24hrs
9.6.3 21mg/24hrs
9.6.4 10mg/16hrs
9.6.5 15mg/16hrs
9.6.6 25mg/16hrs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Withdrawal Clinics
9.10.2 Medical Practice
9.10.3 Individual Smokers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 7mg/24hrs
10.6.2 14mg/24hrs
10.6.3 21mg/24hrs
10.6.4 10mg/16hrs
10.6.5 15mg/16hrs
10.6.6 25mg/16hrs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Withdrawal Clinics
10.10.2 Medical Practice
10.10.3 Individual Smokers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 7mg/24hrs
11.6.2 14mg/24hrs
11.6.3 21mg/24hrs
11.6.4 10mg/16hrs
11.6.5 15mg/16hrs
11.6.6 25mg/16hrs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Withdrawal Clinics
11.10.2 Medical Practice
11.10.3 Individual Smokers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 7mg/24hrs
12.6.2 14mg/24hrs
12.6.3 21mg/24hrs
12.6.4 10mg/16hrs
12.6.5 15mg/16hrs
12.6.6 25mg/16hrs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Withdrawal Clinics
12.10.2 Medical Practice
12.10.3 Individual Smokers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 7mg/24hrs
13.6.2 14mg/24hrs
13.6.3 21mg/24hrs
13.6.4 10mg/16hrs
13.6.5 15mg/16hrs
13.6.6 25mg/16hrs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Withdrawal Clinics
13.10.2 Medical Practice
13.10.3 Individual Smokers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transdermal Nicotine Patch Market: Competitive Dashboard
14.2 Global Transdermal Nicotine Patch Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Novartis
14.3.3 Johnson & Johnson
14.3.4 Perrigo Company
14.3.5 Mylan
14.3.6 Dr. Reddy's Laboratories
14.3.7 Rusan Pharma
14.3.8 GlaxoSmithKline
